IVT Medical Ltd.

IVT Medical Ltd. is a research and development company specializing in advanced wound healing and closure technologies. The company develops innovative medical devices and methodologies for complex wound management across surgical, orthopedic, cardiothoracic, vascular, and trauma care specialties. Their core product lines include the TopClosure® Tension Relief System (TRS), which leverages stress relaxation and mechanical creep to redistribute tension away from wound edges, enabling closure of high-tension wounds and often eliminating the need for skin grafts or flaps. The Vcare α® is a stationary regulated negative pressure wound therapy device incorporating Regulated Oxygen-Enriched and Irrigation-Negative Pressure-Assisted Wound Treatment (ROINPT) technology to combat anaerobic infections through oxygen application. The MeCare α® extends this technology into portable, home-use applications for small to medium wounds, chronic ulcers, burns, flaps, and grafts. IVT Medical also developed the Controlled In-Situ Targeted Ultra-High Concentration Antibiotic Administration (CITA) methodology, enabling direct delivery of antibiotics at infection sites at ultra-high concentrations to overcome resistant infections and biofilms. The company offers consulting and educational services to help healthcare providers integrate advanced wound management solutions. Products are designed with safety-focused electronics and software, including bleeding detection and alarm systems compliant with IEC-60601-1-8 standards. The company is led by CEO Moris Topaz, MD, PhD, with over 15 years of clinical research and basic science development behind their technologies.